List of insiders holdings for RIGEL PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| MPM BIOEQUITIES MASTER FUND LP MPM BIOEQUITIES GP LP MPM BIOEQUITIES GP LLC MPM BIOEQUITIES FUND GMBH & CO KG EVNIN LUKE GADICKE ANSBERT LIPTAK ROBERT EMSTER KURT VON 10% Owner | 2004-02-23 20:17:11 | 0 4,350,516 | 4,350,516 | Form 4 |
| EVNIN LUKE GADICKE ANSBERT Former 10% Owner | 2004-09-15 17:53:50 | 0 2,637,124 | 2,637,124 | Form 4 |
| MPM BIOVENTURES III QP LP MPM BIOVENTURES III LP MPM BIOVENTURES III GMBH & CO MPM BIOVENTURES III PARALLEL FUND MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC GALAKATOS NICHOLAS STEINMETZ MICHAEL WHEELER KURT Former 10% Owner | 2004-09-15 17:55:55 | 0 2,637,124 | 2,637,124 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC 10% Owner | 2014-03-12 17:18:20 | 2,576,707 0 | 2,576,707 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC INVESTMENT 10 LLC BVF INC LAMPERT MARK N 10% Owner | 2014-03-12 17:18:20 | 2,576,707 0 | 2,576,707 | Form 13G |
| FRAZIER HEALTHCARE IV LP FHM IV LP FHM IV LLC 10% Owner | 2004-02-24 20:33:18 | 1,217,467 6,180 | 1,223,647 | Form 4 |
| DELEAGE JEAN ALTA PARTNERS ALTA CALIFORNIA PARTNERS LP ALTA EMBARCADERO PARTNERS LLC ALTA CALIFORNIA MANAGEMENT PARTNERS LP GRUENER GARRETT NOHRA GUY P Director | 2004-11-02 15:45:19 | 809,141 0 | 809,141 | Form 13G |
| Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS LP DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD DEERFIELD INTERNATIONAL LTD Possible Member of 10% Group 10% Owner | 2014-02-14 15:46:12 | 788,675 0 | 788,675 | Form 13G |
| GOWER JAMES M CEO & Board Chairman | 2014-03-03 18:47:40 | 250,000 0 | 250,000 | Form 4 |
| Rojkjaer Lisa EVP, Chief Medical Officer | 2024-03-29 16:09:32 | 187,500 0 | 187,500 | Form 4 |
| Furey Raymond J. EVP, GC, CCO & Corp Sec | 2024-03-01 19:14:43 | 172,250 0 | 172,250 | Form 4 |
| Grossbard Elliott B EVP, CMO | 2016-01-28 18:46:53 | 150,000 0 | 150,000 | Form 4 |
| MOOS WALTER H Director | 2024-05-29 19:21:08 | 132,222 0 | 132,222 | Form 4 |
| LAPOINTE ANTHONY GREGG Director | 2024-05-29 19:20:45 | 130,000 0 | 130,000 | Form 4 |
| Kotzin Brian L. Director | 2024-05-29 19:20:29 | 130,000 0 | 130,000 | Form 4 |
| Wasman Jane Director | 2024-05-29 19:21:27 | 130,000 0 | 130,000 | Form 4 |
| HANNAH ALISON L. Director | 2024-05-29 19:20:11 | 111,250 0 | 111,250 | Form 4 |
| LYONS GARY A Director | 2023-07-12 18:45:31 | 105,000 0 | 105,000 | Form 4 |
| Ali-Jackson Kamil Director | 2024-05-29 19:19:26 | 98,750 0 | 98,750 | Form 4 |
| VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | 2022-09-16 16:15:53 | 81,250 0 | 81,250 | Form 4 |
| Mayer Eldon C. III EVP & Chief Commercial Officer | 2019-11-20 20:15:07 | 75,000 0 | 75,000 | Form 4 |
| Duliege Anne-Marie EVP & Chief Medical Officer | 2019-03-22 19:19:52 | 75,000 0 | 75,000 | Form 4 |
| Maynard Ryan D EVP & CFO | 2017-11-07 21:07:01 | 75,000 0 | 75,000 | Form 4 |
| Dummer Wolfgang EVP & CMO | 2023-02-06 17:40:17 | 72,459 0 | 72,459 | Form 4 |
| Goodwin Bradford S Director | 2021-05-21 21:09:06 | 65,000 0 | 65,000 | Form 4 |
| Markel Stacy EVP Human Resources | 2019-03-22 19:26:33 | 62,500 0 | 62,500 | Form 4 |
| Masuda Esteban Sr. VP Research | 2019-11-20 20:18:03 | 62,500 0 | 62,500 | Form 4 |
| Katkin Keith Director | 2021-05-21 20:57:44 | 55,000 0 | 55,000 | Form 4 |
| PAYAN DONALD G EVP, Pres. Discovery&Research | 2016-09-01 18:18:46 | 0 53,031 | 53,031 | Form 4 |
| WELCH JAMES H CFO, VP & Secretary | 2006-01-27 17:30:21 | 45,000 0 | 45,000 | Form 4 |
| Lasaga Joseph Sr.VP Bus.Dev.Alliance Mgmt. | 2019-11-20 20:20:48 | 43,750 0 | 43,750 | Form 4 |
| SHERWIN STEPHEN A Director | 2016-05-12 19:03:34 | 40,000 0 | 40,000 | Form 4 |
| RINGROSE PETER S Director | 2018-05-18 21:37:52 | 40,000 0 | 40,000 | Form 4 |
| RODRIGUEZ RAUL R CEO, President | 2024-11-26 20:01:20 | 30,000 0 | 30,000 | Form 4 |
| ALTA PARTNERS II INC ALTA BIOPHARMA PARTNERS II LP ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC CHAMPSI FARAH MARDUEL ALIX ALTA BIOPHARMA MANAGEMENT II LLC X-ref Alta Partners II 5/20/04 | 2004-08-24 18:18:30 | 0 29,715 | 29,715 | Form 4 |
| Cabatuan Nelson VP,Finance & Princ.Acctg. Off. | 2020-05-15 20:57:24 | 20,000 0 | 20,000 | Form 4 |
| RENTON HOLLINGS Director | 2013-05-28 19:14:59 | 15,000 0 | 15,000 | Form 4 |
| DELEAGE JEAN Director | 2010-05-28 18:55:18 | 15,000 0 | 15,000 | Form 4 |
| SIMON NICHOLAS J III Director | 2005-06-03 15:36:54 | 10,000 0 | 10,000 | Form 4 |
| COOPER ROBIN D G Sr. V.P. Pharmaceutical Scs. | 2008-02-04 19:49:51 | 10,000 0 | 10,000 | Form 4 |
| Santos David A EVP, Chief Commercial Officer | 2024-11-26 20:01:34 | 8,000 0 | 8,000 | Form 4 |
| Schorno Dean L EVP & Chief Financial Officer | 2024-11-26 20:01:06 | 6,250 0 | 6,250 | Form 4 |
| FRAZIER ALAN D Director | 2006-08-08 20:38:40 | 556 0 | 556 | Form 4 |
| HENNER DENNIS Director | 2005-01-10 16:36:04 | 0 0 | 0 | Form 4 |